BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 237 filers reported holding BLUEPRINT MEDICINES CORP in Q2 2020. The put-call ratio across all filers is 1.19 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $41,225 | -99.1% | 941 | -97.8% | 0.00% | -100.0% |
| Q4 2021 | $4,504,000 | +59.2% | 42,053 | +52.8% | 0.02% | +25.0% |
| Q3 2021 | $2,830,000 | -72.1% | 27,522 | -76.1% | 0.01% | -75.0% |
| Q2 2021 | $10,129,000 | -28.2% | 115,159 | -8.5% | 0.05% | -38.5% |
| Q4 2020 | $14,111,000 | +216.7% | 125,827 | +65.1% | 0.08% | +47.2% |
| Q1 2020 | $4,456,000 | +885.8% | 76,195 | +1217.1% | 0.05% | +2550.0% |
| Q3 2018 | $452,000 | -97.8% | 5,785 | -97.5% | 0.00% | -97.7% |
| Q1 2018 | $20,866,000 | +536.2% | 227,549 | +423.1% | 0.09% | +770.0% |
| Q4 2017 | $3,280,000 | -47.8% | 43,500 | -51.8% | 0.01% | -60.0% |
| Q3 2017 | $6,285,000 | – | 90,207 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 423,012 | $41,129,000 | 7.43% |
| Eagle Health Investments LP | 133,163 | $12,947,000 | 5.08% |
| DAFNA Capital Management LLC | 207,911 | $20,215,000 | 4.80% |
| Casdin Capital, LLC | 1,550,000 | $150,707,000 | 4.49% |
| SIB LLC | 65,151 | $6,335,000 | 3.72% |
| CADIAN CAPITAL MANAGEMENT, LP | 913,702 | $88,839,000 | 3.29% |
| Integral Health Asset Management, LLC | 117,500 | $11,425,000 | 3.26% |
| Rock Springs Capital Management LP | 746,732 | $72,605,000 | 1.58% |
| Avidity Partners Management LP | 546,000 | $53,088,000 | 1.47% |
| Zebra Capital Management LLC | 12,698 | $1,235,000 | 1.36% |